Evidence map›Paper›PMID 26023318›Full record

ArticleChemistry Central journal2015

A facile, stereoselective, one-pot synthesis of resveratrol derivatives.

Vishal C Birar, Angela N Sheerin, Jana Milkovicova, Richard G A Faragher, Elizabeth L Ostler

Abstract read
In one paragraph

Article in Chemistry Central journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vishal C BirarAgeing Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, BN2 4GJ Brighton, UK.
Angela N SheerinAgeing Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, BN2 4GJ Brighton, UK.
Jana MilkovicovaAgeing Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, BN2 4GJ Brighton, UK.
Richard G A FaragherAgeing Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, BN2 4GJ Brighton, UK.
Elizabeth L OstlerAgeing Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, BN2 4GJ Brighton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCompounds based on trans-1,2-diphenylethene are the subject of intense interest both for their optical properties and as potential leads for drug discovery, as a consequence of their anticancer, anti-inflammatory and antioxidant properties. Perhaps the best known of these is trans-3,5,4'-trihydroxystilbene (resveratrol), that has been identified as a promising lead in the search for anti-ageing therapeutics.

resultsWe report here a new, convenient, one-pot stereo-selective synthesis of resveratrol and other trans-stilbene derivatives. A wide range of known and novel "Resveralogues" were synthesised by using this simple protocol, including examples with electron donating and electron withdrawing substituents, in uniformly high yield. The structures of all compounds were confirmed by standard methods including (1)H and (13)C NMR, IR and High Resolution Mass spectroscopy.

conclusionsWe have established a simple and convenient protocol for resveralogue synthesis. It is readily scalable, and sufficiently robust and simple for ready use in automated synthesis or for library development of resveralogues. This supersedes previously reported synthetic methods that required inert conditions, extensive purification and/or costly reagents. Graphical abstractOne-pot preparation of diverse Resveralogues - high yields of product with minimal purification.

Indexed as

AgeingResveratrolStilbene

Identifiers

PMID26023318
PMCPMC4446909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.